KOREA LIFE SCIENCE WEEK

2020 Exhibitors Search

QURATIS Inc.

Booth no. G23
Country Korea, South
Address
Tel (Rep.) 02-866-0604
E-mail undecided
Website http://www.quratis.com

Company Introduction

QURATIS is developing a tuberculosis vaccine (QTP101) for adolescents and adults. It has secured a number of new technologies that are more advanced than existing technologies in cooperation with excellent domestic and foreign research institutes. It is developing a product portfolio including a platform technology and PNA-based new concept antibiotics for various diseases. In September 2020, the Osong Bio Plant was completed, and CDMO service is also in progress.

Promotional video

Exhibit Item

QTP101

Exhibit Item Images

  • Exhibit Name : QTP101
    Tuberculosis Vaccine for adolescents and adults. QTP101 has four antigens (three for virulence and one latency) and a synthetic adjuvant(GLA-SE) to boost the immunity, which is our key competitive advantage.
  • prod
    Exhibit Name : product name : undecided
    undecided
  • prod
    Exhibit Name : product name : undecided
    undecided
  • prod
    Exhibit Name : product name : undecided
    undecided
  • prod
    Exhibit Name : product name : undecided
    undecided

Exhibit Description

QTP101 is TB vaccine for adolescents and adults.
QTP101 has four antigens (three for virulence and one latency) and a synthetic adjuvant(GLA-SE) to boost the immunity, which is our key competitive advantage.

Co-Exhibitor or Partner’s Information

Company Name Country
undecidedundecided
Website http://
Website http://
Website http://
List